Pinar Iyidogan

USPTO Granted Patents = 15 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 56(Granted Patents)

Company Filing History:

Pacific Biosciences of California, Inc.

Years Active: 2019-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404549 - Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes (2025-09-02),

2. 11976323 - Method of nucleic acid sequence determination (2024-05-07),

3. 11913038 - Engineered polymerases for improved sequencing (2024-02-27),

4. 11873516 - Engineered polymerases for improved sequencing by binding (2024-01-16),

5. 11242557 - Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes (2022-02-08),

6. 11242512 - Engineered polymerases for improved sequencing (2022-02-08),

7. 11203779 - Sequencing method for rapid identification and processing of cognate nucleotide pairs (2021-12-21),

8. 11203778 - Sequencing method employing ternary complex destabilization to identify cognate nucleotides (2021-12-21),

9. 10731141 - Engineered polymerases for improved sequencing (2020-08-04),

10. 10633692 - Sequencing method employing ternary complex destabilization to identify cognate nucleotides (2020-04-28),

11. 10597643 - Polymerases engineered to reduce nucleotide-independent DNA binding (2020-03-24),

12. 10584379 - Method of nucleic acid sequence determination (2020-03-10),

13. 10428378 - Sequencing method for rapid identification and processing of cognate nucleotide pairs (2019-10-01),

14. 10400272 - Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes (2019-09-03),

15. 10294514 - Sequencing method employing ternary complex destabilization to identify cognate nucleotides (2019-05-21),

Title: Pinar Iyidogan: Innovator in Nucleic Acid Sequencing

Introduction

Pinar Iyidogan is an accomplished inventor based in San Diego, California, recognized for his significant contributions to the field of nucleic acid sequencing. With a remarkable portfolio of 14 patents, his innovations seek to enhance the efficiency and accuracy of DNA sequencing processes.

Latest Patents

Among his latest patents is the "Method of Nucleic Acid Sequence Determination." This invention introduces a sequencing-by-binding method that employs a specialized DNA polymerizing enzyme. This enzyme is designed to bind the correct nucleotide downstream of a primer without facilitating phosphodiester bond formation. It enables the interrogation of one nucleotide at a time, utilizing labeled nucleotides, such as fluorescent ones, to rapidly establish cognate nucleotide identity.

Another notable patent is for "Engineered Polymerases for Improved Sequencing." This patent covers nucleic acids that encode engineered polymerases featuring modifications in specific motifs of the enzyme. These engineered DNA polymerases are designed to enhance sequencing capabilities and include variants that are highly similar to known sequences while incorporating amino acid substitutions at targeted positions.

Career Highlights

Pinar has held key positions in notable companies such as Omniome, Inc. and Pacific Biosciences of California, Inc. His work at these organizations has been pivotal in advancing sequencing technology and developing innovative methodologies that contribute to scientific research and biotechnology.

Collaborations

Throughout his career, Pinar has collaborated with esteemed colleagues, including Kandaswamy Vijayan and Mark C Wallen. These partnerships have fostered the exchange of ideas and further innovation in the field of genomics.

Conclusion

Pinar Iyidogan's impressive body of work and his innovative patents make him a significant figure in the world of nucleic acid sequencing. His contributions are poised to influence future advancements in the field, ultimately enhancing the capabilities of genomic research and biotechnology applications.

This text is generated by artificial intelligence and may not be accurate.